- Enzymes
- Kits
- Reagents
- Instruments
Glycomics Glycobiology Market size was valued at USD 1,127.6 million in 2022 and is expected to reach a value of USD 2,736.1 million by 2029, growing at a CAGR of 13.5% from 2023-2029. The global market provides a detailed overview of the glycomics glycobiology market and that can be segmented by product, application, and end user. By product, the glycomics glycobiology market has been segmented into enzymes, kits, reagents, and instruments. The enzymes segment is likely to be the largest and fastest-growing segment in terms of product. Further, enzymes are sub-segmented into glycosidases, neuraminidases, glycosyltransferases, sialytransferases, and others. Kits are segregated into glycan labeling kits, glycan purification kits, glycan releases kits, and others. Reagents are segmented into glycoporteins, monosaccharides, oligosaccharides, and others. Instruments is segregated into mass spectrometers, HPLC, MALDI-TOF, array systems, and others. Based on application, the glycomics glycobiology market is segmented into drug discovery and development, diagnostics, and others. Among these, the diagnostics segment is expected to have the fastest-growing market during the forecast period 2022-2028. On the basis of end-users, the market is segregated into academic & research institutes, pharmaceutical & biotechnology companies, CROs, and others. The academic & research institutes held considerable market share during the forecast period.
Glycomics Glycobiology Market Key Developments:
- In Jul 2018, Agilent Technologies acquired ULTRA Scientific. The idea of this acquisition was to expand the company's customer base by offering life sciences solutions.
Glycomics Glycobiology Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
13.5%
Largest Market
North American
Fastest Growing Market
Asia-Pacific
Glycomics/Glycobiology Market Dynamics
Expanding the use of glycan in pharmaceutical research and the creation of novel therapies, increasing research and development spending by the pharmaceutical and biotechnology industries, and the need for drugs to treat a variety of serious chronic conditions are some key factors fueling the market growth
Asia Pacific Got Significant Share
Glycomics/Glycobiology Market Regional Analysis
By region, the Asia Pacific market is expected to witness the highest market share during the forecast period. Glycomics has dramatically increased in the area as a result of the region's developing pharmaceutical and biopharmaceutical sectors. Additionally, Contract Research Organizations (CROs) expenditures in the discovery and manufacturing of pharmaceuticals and biologics are anticipated to boost the expansion of the Asia Pacific market. North America held a considerable market share during the estimated period. The regional market has been pushed by the presence of a well-established healthcare infrastructure and accessibility to cutting-edge products. Government support for R&D initiatives is yet another important element driving the development of the market in this area.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The glycomics glycobiology market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The glycomics glycobiology market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The glycomics glycobiology market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The glycomics glycobiology market report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The glycomics glycobiology market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Glycomics Glycobiology Market Segmentation
By Product
By Application
- Drug Discovery and Development
- Diagnostics
- Others
By End Use
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- CROs
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The Glycomics/Glycobiology Market is projected to expand at a CAGR of 13.5% during the forecast period
The major players in the global glycomics glycobiology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Bruker Corporation (US), New England Biolabs (US), Danaher Corporation (US), Shimadzu Corporation (Japan), Takara Bio, Inc. (Japan), Waters Corporation (US), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), Ludger Ltd. (UK), Asparia Glycomics S.L. (Spain) and Bio-Techne (US)
Asia Pacific is the fastest-growing region for Glycomics/Glycobiology Market
| 1. Executive Summary |
| 2. Global Glycomics/Glycobiology Market Introduction |
| 2.1. Global Glycomics/Glycobiology Market – Taxonomy |
| 2.2. Global Glycomics/Glycobiology Market –Definitions |
| 2.2.1. By Product |
| 2.2.2. By Application |
| 2.2.3. By End Use |
| 2.2.4. By Region |
| 3. Global Glycomics/Glycobiology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Glycomics/Glycobiology Market Dynamic Factors - Impact Analysis |
| 3.6. Global Glycomics/Glycobiology Market – Competition Landscape |
| 4. Global Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Glycomics/Glycobiology Market, By Product, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.1. Enzymes |
| 5.1.1. Glycosidases |
| 5.1.2. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.1.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.4. Market Opportunity Analysis |
| 5.1.5. Neuraminidases |
| 5.1.6. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.1.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.8. Market Opportunity Analysis |
| 5.1.9. Glycosyltransferases |
| 5.1.10. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.1.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.12. Market Opportunity Analysis |
| 5.1.13. Sialytransferases |
| 5.1.14. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.1.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.16. Market Opportunity Analysis |
| 5.1.17. Others |
| 5.1.18. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.1.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.20. Market Opportunity Analysis |
| 5.2. Kits |
| 5.2.1. Glycan Labelling Kits |
| 5.2.2. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.2.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.4. Market Opportunity Analysis |
| 5.2.5. Glycan Purification Kits |
| 5.2.6. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.2.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.8. Market Opportunity Analysis |
| 5.2.9. Glycan Releases Kits |
| 5.2.10. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.2.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.12. Market Opportunity Analysis |
| 5.2.13. Others |
| 5.2.14. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.2.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.16. Market Opportunity Analysis |
| 5.3. Reagents |
| 5.3.1. Glycoporteins |
| 5.3.2. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.3.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.4. Market Opportunity Analysis |
| 5.3.5. Monosaccharides |
| 5.3.6. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.3.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.8. Market Opportunity Analysis |
| 5.3.9. Oligosaccharides |
| 5.3.10. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.3.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.12. Market Opportunity Analysis |
| 5.3.13. Others |
| 5.3.14. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.3.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.16. Market Opportunity Analysis |
| 5.4. Instruments |
| 5.4.1. Mass Spectrometers |
| 5.4.2. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.4.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.4. Market Opportunity Analysis |
| 5.4.5. HPLC |
| 5.4.6. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.4.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.8. Market Opportunity Analysis |
| 5.4.9. MALDI-TOF |
| 5.4.10. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.4.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.12. Market Opportunity Analysis |
| 5.4.13. Array Systems |
| 5.4.14. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.4.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.16. Market Opportunity Analysis |
| 5.4.17. Others |
| 5.4.18. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 5.4.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.20. Market Opportunity Analysis |
| 6. Global Glycomics/Glycobiology Market, By Application, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 6.1. Drug Discovery and Development |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Diagnostics |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Glycomics/Glycobiology Market, By End User, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 7.1. Academic & Research Institutes |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pharmaceutical & Biotechnology Companies |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. CROs |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Glycomics/Glycobiology Market Forecast, By Region, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, By End User and Region, 2023- 2029 |
| 9. North America Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 9.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Enzymes |
| 9.1.1.1. Glycosidases |
| 9.1.1.2. Neuraminidases |
| 9.1.1.3. Glycosyltransferases |
| 9.1.1.4. Sialytransferases |
| 9.1.1.5. Others |
| 9.1.2. Kits |
| 9.1.2.1. Glycan Labelling Kits |
| 9.1.2.2. Glycan Purification Kits |
| 9.1.2.3. Glycan Releases Kits |
| 9.1.2.4. Others |
| 9.1.3. Reagents |
| 9.1.3.1. Glycoporteins |
| 9.1.3.2. Monosaccharides |
| 9.1.3.3. Oligosaccharides |
| 9.1.3.4. Others |
| 9.1.4. Instruments |
| 9.1.4.1. Mass Spectrometers |
| 9.1.4.2. HPLC |
| 9.1.4.3. MALDI-TOF |
| 9.1.4.4. Array Systems |
| 9.1.4.5. Others |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Drug Discovery & Development |
| 9.2.2. Diagnostics |
| 9.2.3. Others |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Academic & Research Institutes |
| 9.3.2. Pharmaceutical & Biotechnology Companies |
| 9.3.3. CROs |
| 9.3.4. Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. U.S. |
| 9.4.2. Canada |
| 9.5. North America Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
| 9.6. North America Glycomics/Glycobiology Market Dynamics – Trends |
| 10. Europe Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 10.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Enzymes |
| 10.1.1.1. Glycosidases |
| 10.1.1.2. Neuraminidases |
| 10.1.1.3. Glycosyltransferases |
| 10.1.1.4. Sialytransferases |
| 10.1.1.5. Others |
| 10.1.2. Kits |
| 10.1.2.1. Glycan Labelling Kits |
| 10.1.2.2. Glycan Purification Kits |
| 10.1.2.3. Glycan Releases Kits |
| 10.1.2.4. Others |
| 10.1.3. Reagents |
| 10.1.3.1. Glycoporteins |
| 10.1.3.2. Monosaccharides |
| 10.1.3.3. Oligosaccharides |
| 10.1.3.4. Others |
| 10.1.4. Instruments |
| 10.1.4.1. Mass Spectrometers |
| 10.1.4.2. HPLC |
| 10.1.4.3. MALDI-TOF |
| 10.1.4.4. Array Systems |
| 10.1.4.5. Others |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Drug Discovery & Development |
| 10.2.2. Diagnostics |
| 10.2.3. Others |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Academic & Research Institutes |
| 10.3.2. Pharmaceutical & Biotechnology Companies |
| 10.3.3. CROs |
| 10.3.4. Others |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
| 10.6. Europe Glycomics/Glycobiology Market Dynamics – Trends |
| 11. Asia-Pacific Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 11.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Enzymes |
| 11.1.1.1. Glycosidases |
| 11.1.1.2. Neuraminidases |
| 11.1.1.3. Glycosyltransferases |
| 11.1.1.4. Sialytransferases |
| 11.1.1.5. Others |
| 11.1.2. Kits |
| 11.1.2.1. Glycan Labelling Kits |
| 11.1.2.2. Glycan Purification Kits |
| 11.1.2.3. Glycan Releases Kits |
| 11.1.2.4. Others |
| 11.1.3. Reagents |
| 11.1.3.1. Glycoporteins |
| 11.1.3.2. Monosaccharides |
| 11.1.3.3. Oligosaccharides |
| 11.1.3.4. Others |
| 11.1.4. Instruments |
| 11.1.4.1. Mass Spectrometers |
| 11.1.4.2. HPLC |
| 11.1.4.3. MALDI-TOF |
| 11.1.4.4. Array Systems |
| 11.1.4.5. Others |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Drug Discovery & Development |
| 11.2.2. Diagnostics |
| 11.2.3. Others |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Academic & Research Institutes |
| 11.3.2. Pharmaceutical & Biotechnology Companies |
| 11.3.3. CROs |
| 11.3.4. Others |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
| 11.6. Asia-Pacific Glycomics/Glycobiology Market Dynamics – Trends |
| 12. Latin America Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2022 - 2028 |
| 12.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Enzymes |
| 12.1.1.1. Glycosidases |
| 12.1.1.2. Neuraminidases |
| 12.1.1.3. Glycosyltransferases |
| 12.1.1.4. Sialytransferases |
| 12.1.1.5. Others |
| 12.1.2. Kits |
| 12.1.2.1. Glycan Labelling Kits |
| 12.1.2.2. Glycan Purification Kits |
| 12.1.2.3. Glycan Releases Kits |
| 12.1.2.4. Others |
| 12.1.3. Reagents |
| 12.1.3.1. Glycoporteins |
| 12.1.3.2. Monosaccharides |
| 12.1.3.3. Oligosaccharides |
| 12.1.3.4. Others |
| 12.1.4. Instruments |
| 12.1.4.1. Mass Spectrometers |
| 12.1.4.2. HPLC |
| 12.1.4.3. MALDI-TOF |
| 12.1.4.4. Array Systems |
| 12.1.4.5. Others |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Drug Discovery & Development |
| 12.2.2. Diagnostics |
| 12.2.3. Others |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Academic & Research Institutes |
| 12.3.2. Pharmaceutical & Biotechnology Companies |
| 12.3.3. CROs |
| 12.3.4. Others |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
| 12.6. Latin America Glycomics/Glycobiology Market Dynamics – Trends |
| 13. Middle East and Africa Glycomics/Glycobiology Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 (Revenue, USD Mn) |
| 13.1. Product Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Enzymes |
| 13.1.1.1. Glycosidases |
| 13.1.1.2. Neuraminidases |
| 13.1.1.3. Glycosyltransferases |
| 13.1.1.4. Sialytransferases |
| 13.1.1.5. Others |
| 13.1.2. Kits |
| 13.1.2.1. Glycan Labelling Kits |
| 13.1.2.2. Glycan Purification Kits |
| 13.1.2.3. Glycan Releases Kits |
| 13.1.2.4. Others |
| 13.1.3. Reagents |
| 13.1.3.1. Glycoporteins |
| 13.1.3.2. Monosaccharides |
| 13.1.3.3. Oligosaccharides |
| 13.1.3.4. Others |
| 13.1.4. Instruments |
| 13.1.4.1. Mass Spectrometers |
| 13.1.4.2. HPLC |
| 13.1.4.3. MALDI-TOF |
| 13.1.4.4. Array Systems |
| 13.1.4.5. Others |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Drug Discovery & Development |
| 13.2.2. Diagnostics |
| 13.2.3. Others |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Academic & Research Institutes |
| 13.3.2. Pharmaceutical & Biotechnology Companies |
| 13.3.3. CROs |
| 13.3.4. Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023- 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Glycomics/Glycobiology Market - Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2023- 2029 |
| 13.6. MEA Glycomics/Glycobiology Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.1.1. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis) |
| 14.1.2. Thermo Fisher Scientific, Inc. (US) |
| 14.1.3. Merck KGaA (Germany) |
| 14.1.4. Agilent Technologies (US) |
| 14.1.5. Bruker Corporation (US) |
| 14.1.6. New England Biolabs (US) |
| 14.1.7. Danaher Corporation (US) |
| 14.1.8. Shimadzu Corporation (Japan) |
| 14.1.9. Takara Bio, Inc. (Japan) |
| 14.1.10. Waters Corporation (US) |
| 14.1.11. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan) |
| 14.1.12. RayBiotech (US) |
| 14.1.13. Z Biotech (US) |
| 14.1.14. Chemily Glycoscience (US) |
| 14.1.15. Dextra Laboratories (UK) |
| 14.1.16. Lectenz Bio (US) |
| 14.1.17. Ludger Ltd. (UK) |
| 14.1.18. Asparia Glycomics S.L. (Spain) |
| 14.1.19. Bio-Techne (US) |
| 14.1.20. Other Companies |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- Thermo Fisher Scientific, Inc. (US)
- Merck KGaA (Germany)
- Agilent Technologies (US)
- Bruker Corporation (US)
- New England Biolabs (US)
- Danaher Corporation (US)
- Shimadzu Corporation (Japan)
- Takara Bio, Inc. (Japan)
- Waters Corporation (US)
- S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
- RayBiotech (US)
- Z Biotech (US)
- Chemily Glycoscience (US)
- Dextra Laboratories (UK)
- Lectenz Bio (US)
- Ludger Ltd. (UK)
- Asparia Glycomics S.L. (Spain)
- Bio-Techne (US)